Cargando…
Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial
BACKGROUND: Although much has evolved in our understanding of the pathogenesis and factors affecting outcome of patients with acute respiratory distress syndrome (ARDS), still there is no specific pharmacologic treatment for ARDS. Several clinical trials have evaluated the utility of corticoids but...
Autores principales: | Villar, Jesús, Belda, Javier, Añón, José Manuel, Blanco, Jesús, Pérez-Méndez, Lina, Ferrando, Carlos, Martínez, Domingo, Soler, Juan Alfonso, Ambrós, Alfonso, Muñoz, Tomás, Rivas, Rosana, Corpas, Ruth, Díaz-Dominguez, Francisco J., Soro, Marina, García-Bello, Miguel Angel, Fernández, Rosa Lidia, Kacmarek, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957909/ https://www.ncbi.nlm.nih.gov/pubmed/27449641 http://dx.doi.org/10.1186/s13063-016-1456-4 |
Ejemplares similares
-
Neurally adjusted ventilatory assist in patients with acute respiratory failure: study protocol for a randomized controlled trial
por: Villar, Jesús, et al.
Publicado: (2016) -
Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
por: Villar, Jesús, et al.
Publicado: (2020) -
Common variants of NFE2L2 gene predisposes to acute respiratory distress syndrome in patients with severe sepsis
por: Acosta-Herrera, Marialbert, et al.
Publicado: (2015) -
Managing Persistent Hypoxemia: what is new?
por: Villar, Jesús, et al.
Publicado: (2017) -
Clinical relevance of timing of assessment of ICU mortality in patients with moderate-to-severe Acute Respiratory Distress Syndrome
por: Villar, Jesús, et al.
Publicado: (2023)